Last hour. The Republic of Moldova received the first batch of Spikevax vaccine, produced by Moderna
Today, November 27, the Republic of Moldova received the first batch of Spikevax vaccine, produced by Moderna. It is about 50,400 doses of vaccine, donated through the COVAX Platform.
Final update: 27.11.2021, 23:41 Published:27.11.2021, 22:40
The vaccine doses have been received by the National Agency for Public Health and will be distributed proportionally in all vaccination centers in our country.
“Receiving a new type of vaccine against COVID-19 and real support for all citizens of the Republic of Moldova. We hope that the new Moderna vaccine will help increase the vaccination rate in our country, so as to form that collective immunity, which will not allow us to stop the spread of the Sars-Cov-2 virus. This is in the context in which we are facing a new danger caused by the appearance of the Omicron strain in the world, including in some European countries. With special gratitude, we thank the partners within the COVAX Platform for the solidarity they show through this support action so vital for us “, declared the Secretary of State of the Ministry of Health, Svetlana Nicolaescu.
The vaccine produced by the modern pharmaceutical company uses technology that is based on messenger RNA. This type of vaccine teaches the human body to create the antibodies needed to fight the SARS-CoV-2 virus. In the Republic of Moldova, people over the age of 18 are administered, according to a two-dose schedule at an interval of 28 days. The vaccine has been approved by the World Health Organization (WHO) and the European Medicines Agency (EMA) for use in emergencies. At the same time, following clinical trials, this vaccine demonstrated 94.1% efficacy for protection against COVID-19 14 days after the first dose.
To get the COVID-19 Spikevax vaccine, contact your family doctor or any other vaccination center in the country. No appointment, only with the identity card.
The immunization campaign was launched on March 2. So far, 931,138 people have completed the vaccination scheme.
The Republic of Moldova was the first country in Europe to receive vaccine doses against COVID-19 through the COVAX platform. Previously, through the same mechanism, 535,590 doses of vaccine were received, of which Astrazeneca – 108,000 doses, Pfizer / BioNtech – 125,190 doses, Janssen / Johnson & Johnson – 302,400 doses.
The COVAX mechanism is led by Gavi, the Vaccine Alliance, the Coalition for Innovation in Epidemic Preparedness (CEPI) and the WHO, together with UNICEF, which is a leader in vaccine procurement and delivery. It is the only global initiative working with governments and manufacturers to ensure that COVID-19 vaccines are available worldwide to both higher-income and lower-income countries.